- Mescaline
- Mescaline acid sulfate
- Mescaline hydrochloride
- 54048-10-1Etonogestrel
- 5404-86-49H-Purine,6-hydrazinyl-
- 54049-24-0Heptanoic acid,7-bromo-, methyl ester
- 540-49-8Ethene, 1,2-dibromo-
- 54050-92-93-Heptyne, 6-methyl-
- 540-51-2Ethanol, 2-bromo-
- 540523-41-92-Pyridinemethanesulfonylchloride
- 54052-90-32-Propenoic acid,2,2,3,4,4,4-hexafluorobutyl ester
- 54053-45-1Butanoic acid,2-chloro-, (2R)-
- 5405-40-32(3H)-Furanone,dihydro-3-hydroxy-4,4-dimethyl-, (3S)-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.
| Name |
Mescaline |
EINECS | N/A |
| CAS No. | 54-04-6 | Density | 1.067g/cm3 |
| PSA | 53.71000 | LogP | 1.91390 |
| Solubility | N/A | Melting Point |
35-36° |
| Formula | C11H17 N O3 | Boiling Point | 312.1°Cat760mmHg |
| Molecular Weight | 211.261 | Flash Point | 145.8°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by intraperitoneal and intravenous routes. Moderately toxic by ingestion route. An experimental teratogen. Other experimental reproductive effects. Human systemic effects by intramuscular route: euphoria and hallucinations, distorted perceptions. A psychotoimetic agent (a drug of abuse). When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | Highly toxic by ingestion. |
| Synonyms |
Phenethylamine,3,4,5-trimethoxy- (8CI); 2-(3,4,5-Trimethoxyphenyl)ethanamine;2-(3,4,5-Trimethoxyphenyl)ethylamine; 3,4,5-Trimethoxy-b-phenethylamine;3,4,5-Trimethoxybenzeneethanamine; 3,4,5-Trimethoxyphenethylamine;3,4,5-Trimethoxyphenylethylamine; Mescalin; Mescaline; Mezcaline; NSC 30419;TMPEA |
Article Data | 46 |
Mescaline Chemical Properties
IUPAC Name: 2-(3,4,5-Trimethoxyphenyl)ethanamine
Synonyms: 2-(3,4,5-Trimethoxyphenyl)ethanamine ; 2-(3,4,5-Trimethoxyphenyl)ethylamine ; 3,4,5-Trimethoxy-b-phenethylamine ; Benzeneethanamine, 3,4,5-trimethoxy-
CAS NO: 54-04-6
Molecular Formula of Mescaline (CAS NO.54-04-6) : C11H17NO3
Molecular Weight of Mescaline (CAS NO.54-04-6) : 211.25758
Molecular Structure of Mescaline (CAS NO.54-04-6) : 
EINECS: 200-190-7
Mol File: 54-04-6.mol
Index of Refraction: 1.511
Surface Tension: 35.4 dyne/cm
Density: 1.067 g/cm3
Flash Point: 145.8 °C
Enthalpy of Vaporization: 55.3 kJ/mol
Boiling Point: 312.1 °C at 760 mmHg
Vapour Pressure: 0.000541 mmHg at 25°C
Appearance:White Powder
Mescaline Uses
Mescaline (CAS NO.54-04-6) is psychedelic alkoloid.
Mescaline Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| frog | LDLo | parenteral | 750mg/kg (750mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Journal of Pharmacology and Experimental Therapeutics. Vol. 50, Pg. 359, 1934. |
| guinea pig | LDLo | subcutaneous | 500mg/kg (500mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Journal of Pharmacology and Experimental Therapeutics. Vol. 50, Pg. 359, 1934. |
| human | TDLo | intramuscular | 2500ug/kg (2.5mg/kg) | BEHAVIORAL: EUPHORIA BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | Psychopharmacologia Vol. 3, Pg. 219, 1962. |
| mouse | LD50 | intraperitoneal | 315mg/kg (315mg/kg) | Journal of Medicinal Chemistry. Vol. 13, Pg. 26, 1970. | |
| mouse | LD50 | intravenous | 157mg/kg (157mg/kg) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64, Pg. 159, 1968. | |
| mouse | LD50 | oral | 880mg/kg (880mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 131, Pg. 115, 1961. | |
| mouse | LD50 | subcutaneous | 534mg/kg (534mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 58, Pg. 261, 1962. |
| mouse | LD50 | unreported | 261mg/kg (261mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Nature. Vol. 218, Pg. 298, 1968. |
| rat | LD50 | intramuscular | 330mg/kg (330mg/kg) | Pharmazie in Unserer Zeit. Vol. 14, Pg. 129, 1985. | |
| rat | LD50 | intravenous | 157mg/kg (157mg/kg) | Pharmazie in Unserer Zeit. Vol. 14, Pg. 129, 1985. | |
| rat | LD50 | subcutaneous | 534mg/kg (534mg/kg) | Pharmazie in Unserer Zeit. Vol. 14, Pg. 129, 1985. |
Mescaline Safety Profile
Poison by intraperitoneal and intravenous routes. Moderately toxic by ingestion route. An experimental teratogen. Other experimental reproductive effects. Human systemic effects by intramuscular route: euphoria and hallucinations, distorted perceptions. A psychotoimetic agent (a drug of abuse). When heated to decomposition it emits toxic fumes of NOx.